NCT02563184View on ClinicalTrials.gov

Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease

PHASE4UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
BIOLOGICAL

Fluzone

Trial Locations (1)

85006

RECRUITING

Pulmonary Associates, Phoenix

Sponsors

Lead Sponsor

Banner Health
All Listed Sponsors
collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

lead

Banner Health

OTHER